Abstract
We report a genome-wide association study in 10,286 cases and 9,135 controls of European ancestry in the Cancer Genetic Markers of Susceptibility (CGEMS) initiative. We identify a new association with prostate cancer risk on chromosome 8q24 (rs620861, P = 1.3 × 10−10, heterozygote OR = 1.17, 95% CI 1.10–1.24; homozygote OR = 1.33, 95% CI 1.21–1.45). This defines a new locus associated with prostate cancer susceptibility on 8q24.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Amundadottir, L.T. et al. Nat. Genet. 38, 652–658 (2006).
Freedman, M.L. et al. Proc. Natl. Acad. Sci. USA 103, 14068–14073 (2006).
Gudmundsson, J. et al. Nat. Genet. 39, 631–637 (2007).
Haiman, C.A. et al. Nat. Genet. 39, 638–644 (2007).
Thomas, G. et al. Nat. Genet. 40, 310–315 (2008).
Easton, D.F. et al. Nature 447, 1087–1093 (2007).
Haiman, C.A. et al. Nat. Genet. 39, 954–956 (2007).
Zanke, B.W. et al. Nat. Genet. 39, 989–994 (2007).
Tomlinson, I. et al. Nat. Genet. 39, 984–988 (2007).
Kiemeney, L.A. et al. Nat. Genet. 40, 1307–1312 (2008).
Pomerantz, M.M. et al. Nat. Genet. 41, 882–884 (2009).
Witte, J.S. Nat. Genet. 39, 579–580 (2007).
Ghoussaini, M. et al. J. Natl. Cancer Inst. 100, 962–966 (2008).
Berndt, S.I. et al. Hum. Mol. Genet. 17, 2665–2672 (2008).
Wokolorczyk, D. et al. Cancer Res. 68, 9982–9986 (2008).
Acknowledgements
This project was funded in part using grants CA129684 to J.X. and CA131338 to S.L.Z. This project was funded in whole or in part with federal funds from the NCI, National Institutes of Health (NIH), under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services (DHHS), nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.
Author information
Authors and Affiliations
Contributions
M.Y., N.C. and S.J.C. drafted the manuscript; N.C., J.C., K.B.J., Z.W. and M.Y. performed statistical analyses; K.B.J., N.C., J.G.-B., P.K., S.W., N.O., K.Y. and L.A. made important suggestions to the analytic plan and/or aided interpretation of results; A.H. led the genotyping efforts; R.B.H., S.B., H.S.F., M.J.T., W.R.D., D.A., J.V., S.W., F.R.S., G.C.-T., O.C., A.V., G.L.A., E.D.C., C.A.H., B.H., L.K., L.L.M., A.S., E.R., T.J.K., R.K., W.I., S.I., K.E.W., H.G., F.W., P.S., J.X., S.L.Z., J.S., L.J.V., K.H. and M.K. provided DNA or genotyping data for study subjects; M.T., D.S.G., R.N.H., J.F.F., D.J.H. and G.T. participated in revising the manuscript and provided important intellectual contributions.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1 and 2, Supplementary Tables 1–5 and Supplementary Methods. (PDF 534 kb)
Rights and permissions
About this article
Cite this article
Yeager, M., Chatterjee, N., Ciampa, J. et al. Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet 41, 1055–1057 (2009). https://doi.org/10.1038/ng.444
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.444
This article is cited by
-
The molecular biology of prostate cancer: current understanding and clinical implications
Prostate Cancer and Prostatic Diseases (2018)
-
Prospective evaluation of serum IL-16 and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Cancer Causes & Control (2018)
-
Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21
Scientific Reports (2018)
-
Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer
Nature Communications (2016)
-
Association of three 8q24 polymorphisms with prostate cancer susceptibility: evidence from a meta-analysis with 50,854 subjects
Scientific Reports (2015)